measur
number
copi
dna
mrna
quantit
polymeras
chain
reaction
qpcr
transform
drug
develop
process
transform
driven
inform
measur
contribut
better
understand
molecular
definit
diseas
mechan
efficaci
toxic
new
drug
inform
translat
accur
genom
biomark
efficaci
toxic
drug
develop
process
support
measur
becom
effici
transform
exemplifi
convers
enzym
activ
measur
gene
express
drug
metabol
studi
measur
cytokin
chemokin
genom
express
level
clinic
marker
identif
evalu
genom
biomark
nephrotox
good
understand
factor
affect
qpcr
measur
simplifi
implement
highthroughput
platform
assay
drug
dev
re
polymeras
chain
reaction
pcr
use
almost
two
decad
mulli
et
al
discoveri
enabl
detect
copi
dna
cdna
reversetranscriptas
reaction
measur
gene
express
level
thermal
cycler
reagent
primer
design
softwar
quickli
develop
caroth
et
al
support
spread
technolog
academ
industri
govern
laboratori
initi
applic
pcr
focus
qualit
use
link
electrophoret
product
identif
sever
approach
develop
quantit
real
time
pcr
henco
heibey
landgraf
et
al
order
convert
qualit
inform
pcr
gel
quantit
result
pcr
product
accur
quantifi
gel
fundament
limit
prevent
accur
quantif
pcr
product
reflect
accur
origin
quantiti
dna
cdna
sampl
endpoint
measur
pcr
product
amplif
cycl
weak
correl
origin
number
copi
templat
sampl
correl
attain
limit
dynam
rang
powel
kroon
ferr
quantit
real
time
pcr
qpcr
heid
et
al
wittwer
et
al
develop
last
decad
tool
accur
measur
templat
copi
number
theori
behind
method
straightforward
assum
pcr
effici
constant
close
throughout
amplif
cycl
use
livak
schmittgen
number
copi
templat
sampl
determin
amplif
cycl
c
amplif
product
initi
detect
detect
chemistri
taqman
livak
et
al
sybr
green
morrison
et
al
allow
detect
product
within
logarithm
growth
rang
reaction
well
normal
gene
express
measur
endogen
control
gene
number
copi
ribosom
rna
sampl
taqman
chemistri
also
allow
multiplex
sever
realtim
quantit
pcr
reaction
reaction
volum
lee
et
al
multiplex
major
advantag
accur
normal
sinc
expos
pcr
reaction
quantif
target
endogen
control
gene
chemic
matrix
drug
develop
applic
qpcr
winer
et
al
publish
within
year
first
technic
paper
subject
heid
et
al
applic
includ
detect
minim
residu
diseas
acut
myeloid
leukemia
marcucci
et
al
jaeger
kainz
search
genom
biomark
efficaci
toxic
slack
et
al
walker
clinic
microbiolog
applic
detect
character
drug
resist
multipl
viral
strain
josefsson
et
al
niester
bacteri
matsuki
et
al
protozoan
parasit
bell
ranfordcartwright
fungal
atkin
clark
speci
investig
applic
becom
routin
pharmaceut
industri
biomark
develop
recent
broadli
accept
goodsaid
adopt
qpcr
follow
path
confirmatori
measur
hybrid
experi
rajeevan
et
al
standalon
technolog
driven
univers
guidelin
assay
develop
qpcr
livak
schmittgen
integr
robot
instrument
assembl
qpcr
format
pinhasov
et
al
develop
miniatur
matric
preload
primer
probe
simultan
qpcr
measur
hundr
gene
target
de
mello
specif
sensit
dynam
rang
qpcr
transform
gold
standard
confirmatori
measur
hybrid
experi
confirmatori
measur
may
need
either
quantit
observ
gene
express
chang
qualit
identif
correct
genom
sequenc
rajeevan
et
al
applic
underscor
critic
differ
qpcr
hybrid
hybrid
protocol
optim
around
compromis
sensit
detect
hybrid
sequenc
array
specif
hybrid
individu
sequenc
univers
protocol
qpcr
develop
around
level
pcr
effici
requisit
bind
fluoresc
probe
taqman
minim
detect
nonspecif
amplif
product
fundament
differ
two
genom
technolog
key
determin
eventu
adopt
qpcr
regulatori
context
diagnost
pharmaceut
applic
differ
hybrid
platform
lead
signific
differ
hybrid
result
recent
studi
report
part
collabor
work
intern
life
scienc
institut
health
environment
scienc
institut
ilsihesi
genom
committe
quantit
revers
transcriptionpolymeras
chain
reaction
qrtpcr
use
investig
discrep
result
nieh
cdna
affymetrix
oligo
rat
platform
use
evalu
hepat
gene
express
chang
rat
expos
methapyrilen
caldesmon
cdna
platform
hybrid
result
show
decreas
gene
express
result
compar
control
contrast
affymetrix
oligonucleotid
platform
show
increas
express
level
sampl
case
caldesmon
sequenc
cdna
clone
show
suppress
rel
day
highdos
methapyrilenepool
control
data
demonstr
import
qrtpcr
confirm
key
hybrid
result
well
understand
sourc
discrep
result
differ
hybrid
platform
good
correl
mrna
express
protein
level
mechanist
studi
drug
efficaci
safeti
ultim
requir
result
extrapol
function
protein
enzym
mechan
cytochrom
cyp
gene
express
chang
measur
previous
use
cultur
cell
bowen
et
al
burczynski
et
al
bowen
et
al
show
quantit
gene
express
cyp
induct
could
determin
human
hepatocyt
cultur
correl
function
test
includ
burczynski
et
al
burczynski
et
al
found
good
correl
quantit
gene
express
measur
cyp
induct
rat
hepatocyt
lcmsmsbase
cyp
enzym
assay
result
publish
previous
pan
et
al
use
mice
shown
quantit
gene
express
measur
cyp
enzym
induct
liver
tissu
possibl
studi
howev
comprehens
character
biochem
chang
enzym
recent
studi
goodsaid
compar
tempor
biochem
gene
transcript
chang
rat
liver
cytochrom
convent
approach
assess
cytochrom
cyp
induct
preclin
anim
model
involv
daili
dose
least
week
follow
western
blot
andor
enzym
activ
analysi
studi
simultan
assess
gene
express
qrtpcr
along
western
blot
enzym
activ
assay
time
cours
vivo
model
rat
dose
daili
day
model
induc
liver
level
measur
day
dose
qrtpcr
western
blot
enzym
activ
result
studi
show
gene
maxim
induc
rapidli
day
wherea
gene
maxim
induc
lag
time
day
case
fold
chang
induct
detect
qrtpcr
greater
fold
chang
protein
level
enzym
activ
maxim
persist
larger
fold
chang
observ
qrtpcr
either
preced
occur
simultan
maxim
sustain
fold
chang
protein
level
measur
western
blot
enzym
activ
assay
data
show
qrtpcr
provid
increas
sensit
specif
convent
assay
may
key
inform
reliabl
assess
drugrel
chang
cyp
induct
transit
discoveri
toxicolog
studi
map
express
level
enzym
pglycoprotein
gene
differ
rat
tissu
also
report
qrtpcr
lindel
et
al
express
pgp
found
similar
liver
small
intestin
higher
express
level
detect
liver
small
intestin
studi
underscor
need
studi
contribut
small
intestin
bioavail
drug
metabol
enzym
express
rat
tissu
one
import
drug
develop
applic
qpcr
measur
biomark
drug
efficaci
measur
gene
express
level
chemokin
chemokin
receptor
good
model
advantag
measur
mrna
conjunct
protein
product
level
well
convers
genom
biomark
identifi
hybrid
experi
qrtpcr
assay
qrtpcr
assay
chemokin
chemokin
receptor
redefin
standard
sensit
specif
detect
analyt
assay
also
broaden
biolog
matric
context
assay
analyt
may
perform
earlier
applic
qrtpcr
area
investig
receptor
ligand
debet
et
al
qrtpcr
use
work
show
cell
uniqu
coexpress
protein
accessori
protein
requir
highaffin
bind
accessori
protein
antibodi
also
shown
work
strong
antagonist
qrtpcr
also
appli
investig
express
chemokin
chemokin
receptor
two
murin
model
inflammatori
bowel
diseas
scheeren
et
al
increas
gene
express
level
measur
set
gene
chronic
inflam
colon
mice
compar
wild
type
mice
revers
coliti
mice
monoclon
antibodi
follow
inhibit
gene
gene
identifi
lix
lymphotactin
mig
mipbeta
addit
test
previous
identifi
chemokin
chemokin
receptor
biomark
efficaci
applic
also
acceler
character
new
cytokin
cytokin
member
famili
cytokin
induc
prolifer
naiv
cell
gener
adapt
immun
respons
bind
cytokin
receptor
qrtpcr
demonstr
pflanz
et
al
induct
subset
inflammatori
cytokin
primari
human
mast
cell
monocyt
respons
stimul
qrtpcr
test
cytokin
gene
express
use
studi
differenti
regul
express
degranul
antiallerg
compound
rat
basophil
leukemia
cell
vivo
mous
model
matsubara
et
al
olopatadin
antiallerg
drug
function
histamin
h
antagonist
inhibit
mast
cell
degranul
releas
arachidon
acid
metabolit
variou
type
cell
studi
measur
inhibit
express
olopatadin
antiallerg
drug
conclud
suppress
degranul
arachidon
acid
releas
compound
correl
well
inhibit
ca
influx
receptoroper
channel
reduct
express
suggest
addit
mechan
determin
level
cytokin
express
mast
cell
anoth
common
applic
qrtpcr
accur
measur
time
depend
gene
express
subset
gene
previous
identifi
hybrid
experi
exampl
applic
determin
kinet
express
genom
biomark
betaadrenerg
induc
cardiomyopathi
mice
gaussin
et
al
betaadrenerg
receptor
blockad
therapi
use
treatment
heart
failur
mice
overexpress
receptor
protein
kinas
increas
express
level
measur
onset
cardiomyopathi
uncoupl
protein
protein
involv
mitochondri
membran
potenti
fourandahalf
lim
domain
member
lim
protein
famili
treatment
block
beta
adrenerg
receptor
revers
cardiomayopathi
suppress
increas
express
gene
exampl
direct
applic
qrtpcr
valid
biomark
efficaci
publish
valid
pselectin
biomark
atherogenesi
molenaar
et
al
valid
candid
target
develop
antiatherogen
therapi
requir
express
measur
aortic
arch
tissu
apoedefici
apo
mice
qrtpcr
result
measur
show
pselectin
express
increas
age
higher
apo
control
mice
correl
develop
lesion
apo
mice
applic
qrtpcr
investig
genom
biomark
develop
anticanc
drug
focus
sever
model
efficaci
taxol
antiangiogen
effect
human
epitheli
ovarian
carcinoma
cell
line
studi
hata
et
al
measur
effect
taxol
express
level
major
ligand
endotheliumspecif
tyrosinas
kinas
receptor
import
regul
endotheli
cell
surviv
studi
show
express
level
significantli
decreas
exposur
nm
taxol
h
conclus
studi
exposur
ovarian
cancer
cell
low
concentr
taxol
may
inhibit
vascular
regress
consid
trigger
angiogenesi
angiogenesi
also
studi
qrtpcr
human
bone
marrow
kumar
et
al
studi
angiogen
potenti
bone
marrow
plasma
function
express
vegf
bfgf
receptor
plasma
cell
patient
differ
clinic
profil
myeloma
studi
found
signific
differ
express
level
gene
plasma
cell
differ
patient
conclud
angiogen
potenti
correl
tumor
burden
rather
increas
express
vegfbfgf
broader
benefit
associ
novel
biomark
test
possibl
evalu
across
multipl
speci
interest
preclin
drug
safeti
evalu
davi
et
al
recent
show
correl
rat
kidney
toxic
gene
express
chang
report
ilsi
genom
committe
amin
et
al
also
observ
qrtpcr
cynomolgu
monkey
work
show
express
chang
gene
particularli
kidney
injuri
molecul
han
et
al
clusterin
correarot
et
al
highli
predict
develop
tubular
necrosi
earli
detect
toxic
kidney
tissu
measur
chang
transcript
level
may
also
possibl
urin
measur
chang
protein
product
level
han
et
al
studi
davi
et
al
emphas
need
identifi
safeti
biomark
dose
protocol
length
match
applic
biomark
anchor
chang
report
level
genom
biomark
histolog
data
support
claim
show
novel
biomark
either
sensit
specif
current
accept
marker
also
provid
valid
across
speci
propos
biomark
gene
express
measur
across
speci
possibl
qrtpcr
primer
design
sequenc
conserv
across
speci
report
davi
et
al
express
sever
monkey
gene
measur
primer
design
sequenc
conserv
rat
human
gene
higheffici
qrtpcr
requir
match
primer
design
conserv
region
two
known
sequenc
actual
sequenc
third
previous
unknown
genom
sequenc
requir
approxim
effici
qrtpcr
make
sequenc
match
absolut
requir
genom
platform
also
facilit
valid
slope
graph
show
c
valu
function
templat
dilut
known
unknown
sequenc
use
valid
choic
primer
sequenc
everincreas
knowledg
genom
sequenc
speci
interest
drug
safeti
evalu
reduc
need
approach
primer
design
qrtpcr
qrtpcr
also
appli
measur
genom
biomark
gastrointestin
toxic
searfoss
et
al
function
gammasecretas
inhibitor
block
cleavag
sever
transmembran
protein
includ
amyloid
precursor
protein
cell
fate
regul
inhibit
app
process
lead
blockag
gener
amyloid
beta
peptid
gamma
secretas
inhibitor
consid
candid
therapi
patient
alzheim
diseas
mechanismdepend
effect
gammasecretas
inhibitor
gastrointestin
toxic
cell
popul
chang
ileum
rat
model
microarray
analysi
use
studi
identifi
number
gene
whose
express
level
correl
develop
endpoint
qrtpcr
use
accur
quantif
adipsin
import
biomark
identifi
studi
vitro
result
preadipocyt
report
studi
demonstr
gamma
secretas
inhibitor
inhibit
express
upregul
adipsin
express
block
preadipocyt
differenti
accur
measur
gene
express
found
multipl
clinic
microbiolog
applic
relev
drug
develop
qpcr
assay
develop
recent
detect
francisella
tularensi
mcavin
et
al
specif
genet
lineag
anaplasma
phagocytophilum
ixod
ricinu
tick
polin
et
al
periodotopath
bacteria
tannarella
forsythensi
fusobacterium
spp
periodont
pocket
suzuki
et
al
candida
albican
concentr
oral
rins
cultur
white
et
al
shigella
thiem
et
al
human
herpesviru
epsteinbarr
viru
friedrich
et
al
parvoviru
mutant
hokynar
et
al
sever
acut
respiratori
syndrom
sar
coronaviru
hourfar
et
al
drosten
et
al
hui
et
al
drug
resist
gene
express
also
measur
qrtpcr
candida
albican
frade
et
al
sensit
dynam
rang
assay
also
compar
work
correspond
northern
hybrid
assay
correl
qrtpcr
northern
hybrid
excel
except
detect
low
level
express
qrtpcr
northern
hybrid
linear
respons
qrtpcr
induct
inaccur
quantifi
northern
hybrid
test
detect
clarithromycin
resist
helicobact
pylori
evalu
gastric
biopsi
specimen
qpcr
lascol
et
al
studi
found
sensit
detect
h
pylori
qpcr
better
specif
detect
cultur
histolog
qpcr
capabl
quantif
littl
minimum
detect
dynam
rang
h
pylori
qpcr
also
correctli
sort
clarithromycin
suscept
resist
strain
concord
current
method
highthroughput
screen
applic
quantit
gene
express
requir
valid
cell
model
well
platform
sensit
dynam
rang
lead
accur
priorit
candid
compound
result
review
vitro
studi
focus
biomark
efficaci
effort
assembl
effici
highthroughput
qrtpcr
measur
protocol
also
focus
biomark
safeti
pinhasov
et
al
drug
metabol
perez
et
al
johnson
johnson
pharmaceut
research
pinhasov
et
al
robot
system
seamlessli
merg
rna
isol
purif
reversetranscriptas
reaction
deliveri
sampl
reagent
plate
configur
flexibl
lead
either
maximum
number
sampl
maximum
number
genom
target
target
identif
valid
structureact
sar
studi
compound
select
efficaci
studi
biomark
identif
run
highthroughput
genom
platform
develop
qrtpcr
assay
close
link
straightforward
rule
valid
earli
develop
technolog
livak
schmittgen
plugandplay
charact
qrtpcr
requir
follow
taq
polymeras
enzym
reaction
maximum
effici
chemic
matrix
commerci
avail
master
mix
optim
maximum
rate
stabil
differ
taq
enzym
primer
probe
design
accur
chemic
matric
commerci
avail
master
mix
primer
probe
design
softwar
product
primer
expresst
livak
schmittgen
match
master
mix
suppli
vendor
maximum
pcr
effici
throughout
rang
c
express
result
need
critic
rel
quantif
specif
method
develop
meijerink
et
al
compens
effect
sampl
matrix
effect
measur
choic
endogen
control
gene
rel
quantif
reason
endogen
control
gene
chosen
express
remain
unchang
throughout
studi
depend
exclus
total
amount
rna
sampl
excel
choic
endogen
control
gene
rna
express
level
essenti
constant
endogen
control
gene
chosen
proxim
express
target
gene
approach
prevent
accur
multiplex
disengag
revers
transcriptas
taq
polymeras
reaction
optim
master
mix
two
reaction
possibl
consid
independ
singlestep
qrtpcr
chemistri
compromis
sensit
dynam
rang
qrtpcr
valuabl
asset
lab
interest
quantit
gene
express
measur
longterm
storag
rel
stabl
revers
transcript
cdna
product
individu
test
sampl
success
highthroughput
screen
applic
summar
close
link
uniqu
logic
qpcr
tabl
qpcr
succeed
multipl
applic
conceiv
begin
plugandplay
method
univers
gener
biochem
matrix
regardless
commerci
sourc
qpcr
reagent
basic
physicochem
logic
retain
assay
genom
target
may
assembl
primer
probe
design
softwar
higheffici
pcr
reaction
hybrid
platform
whether
oligonucleotideor
cdnabas
often
proprietari
menu
configur
label
hybrid
chemistri
hybrid
analysi
hardwar
softwar
hybrid
platform
also
focu
densiti
inform
avail
hundr
simultan
gene
express
result
necessarili
sensit
specif
dynam
rang
method
clear
measur
essenti
longterm
develop
valid
glp
protocol
gene
express
measur
format
densiti
qpcr
yet
exceed
rang
hundr
gene
sampl
limit
inher
platform
would
prevent
success
develop
higher
densiti
plate
microfluid
devic
eas
valid
glp
protocol
may
develop
qpcr
suggest
platform
becom
futur
standard
gene
express
measur
drug
develop
confirm
valid
dna
hybrid
result
studi
molecular
mechan
diseas
earli
target
identif
convers
qualit
hybrid
test
sensit
quantit
reproduc
test
set
gene
sensit
accur
measur
clinic
microbiolog
virolog
highthroughput
test
platform
genom
biomark
efficaci
safeti
impact
drug
develop
convers
drug
metabol
enzym
activ
measur
highsensit
gene
express
measur
preclin
test
marker
efficaci
safeti
studi
mechan
druginduc
toxic
